Clinico-pathologic Evaluation of Patients with Hemangioendothelioma: A 10-year Experience from Shiraz, Southern of Iran

Authors

  • Mohammad Hossein Anbardar Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mohammad Ali Rahmani Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
  • Ali Ameli Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran
  • Sholeh Afshinpoor Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran
  • Hamid Zaferani Arani Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
  • Nastaran Fooladivanda Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: Hemangioendothelioma (HE) represents a group of rare, borderline malignant vascular tumors with diverse clinical presentations and diagnostic challenges. This study aims to investigate the demographic, clinical, radiological data, histological findings, treatment modalities, survival rates, and other key characteristics of HE cases in both pediatric and adult patients. Materials and Methods: This is a case series cross-sectional study conducted at Namazi Teaching Hospital and Abuali Sina Hospital, Shiraz University of Medical Sciences. The study involved a retrospective review of medical records from 2009 to 2019, focusing on 22 patients diagnosed with HE. Data were collected using a standardized collection form. For precise histological examination, tissue slides were extracted and analyzed, incorporating pathological variables and immunohistochemical markers. Results: In this study, a total of 22 patients diagnosed with HE was examined. Their mean age was 40.6 years with male-to-female ratio of 12:10. The majority of cases in this study were diagnosed with hepatic epithelioid HE (59%). The most commonly reported symptoms included abdominal pain and palpable masses. Radiologically, the tumors primarily appeared as hypo-dense lesions, often accompanied by peripheral rim enhancement. Pathologically, the features such as intracytoplasmic vacuolization, eosinophilic cytoplasm, and specific markers (CD31, CD34) were crucial in accurate diagnosis. Importantly, the study also revealed a positive outcome in terms of patient survival, with only 10% of surgically treated patients succumbing to the disease. Conclusion: This study provides a detailed clinico-pathologic evaluation of HE from Southern Iran, underscoring the critical relationship between tumor location and clinical presentation. The research highlights that HE, though rare, can occur in pediatric and adults and must be included in the differential diagnosis of vascular lesions across all age groups. From a therapeutic perspective, surgical intervention emerged as the most effective treatment modality, associated with a notably high survival rate of 90% among operated patients.

References

Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol. 2013; 30(1): 29-44.

https://doi.org/10.1053/j.semdp.2012.01.003

PMid:23327728

Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982; 50(5): 970-81.

https://doi.org/10.1002/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z

PMid:7093931

Stacchiotti S, Miah A, Frezza A, Messiou C, Morosi C, Caraceni A, et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO open. 2021; 6(3): 100170.

https://doi.org/10.1016/j.esmoop.2021.100170

PMid:34090171 PMCid:PMC8182432

Rosenberg A, Agulnik M. Epithelioid hemangioendothelioma: update on diagnosis and treatment. Curr Treat Options Oncol. 2018; 19(4): 1-8.

https://doi.org/10.1007/s11864-018-0536-y

PMid:29546487

Guo Q, Xue J, Xu L, Shi Z, Zhou B. The clinical features of epithelioid hemangioendothelioma in a Han Chinese population: A retrospective analysis. Medicine. 2017; 96(26): e7345.

https://doi.org/10.1097/MD.0000000000007345

PMid:28658152 PMCid:PMC5500074

Li W, Li JK, Zheng X, Chen LL, Yang YH. Clinicopathological features of primary pulmonary epithelioid hemangioendothelioma: a study of 7 cases. Zhonghua Zhong Liu Za Zhi. 2025; 47(3): 269-274.

Deng C, An Y, Liu J, Wang C, Gou H, Zhang J, et al. Hepatic epithelioid hemangioendothelioma, a rare liver tumor: a case report and review of the literature. Front Oncol. 2025; 15: 1522002.

https://doi.org/10.3389/fonc.2025.1522002

PMid:40452839 PMCid:PMC12122502

Mardani P, Shahriarirad R, Nekooeian M, Anbardar MH, Ziaian B, Kamran H, et al. Pleural epithelioid hemangioendothelioma in a 39-Year-old female: a case report. J Cardiothorac Surg. 2024; 19(1): 118.

https://doi.org/10.1186/s13019-024-02602-4

PMid:38475834 PMCid:PMC10935829

Xu J, Hu S, Li S, Wang W, Zhou X, Wu Y, et al. Laparoscopic resection of hepatic epithelioid hemangioendothelioma: report of eleven rare cases and literature review. World J Surg Onc. 2020; 18(1): 1-8.

https://doi.org/10.1186/s12957-020-02034-z

PMid:33121478 PMCid:PMC7596953

Kaur G, Mitra S, Barwad A, Chatterjee D, Dey T, Khosla D, Saikia UN, Kaman L, Dutta U, Duseja A, Das A. Clinical, Histopathological, and Immunophenotypic Spectrum of Hepatic Epithelioid Hemangioendothelioma: Eight Years' Data of a Tertiary Care Center from North India. J Clin Exp Hepatol. 2025; 15(1): 102429.

https://doi.org/10.1016/j.jceh.2024.102429

PMid:39564429 PMCid:PMC11570939

Liu Z, Yi L, Chen J, Li R, Liang K, Chen X, et al. Comparison of the clinical and MRI features of patients with hepatic hemangioma, epithelioid hemangioendothelioma, or angiosarcoma. BMC Med Imaging. 2020; 20: 1-9.

https://doi.org/10.1186/s12880-020-00465-4

PMid:32600273 PMCid:PMC7322860

Shin SH, Koh YS, Song S. Hepatic epithelioid hemangioendothelioma managed with minimally invasive surgery: A case report. World J Clin Cases. 2025; 13(22): 104924.

https://doi.org/10.12998/wjcc.v13.i22.104924

PMid:40771736 PMCid:PMC12188779

Larson EL, Ciftci Y, Jenkins RT, Zhou AL, Ruck JM, Philosophe B. Outcomes of Liver Transplant for Hepatic Epithelioid Hemangioendothelioma. Clin Transplant. 2025; 39(2): e70087.

https://doi.org/10.1111/ctr.70087

PMid:39869081

Shiba S, Imaoka H, Shioji K, Suzuki E, Horiguchi S, Terashima T, et al. Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study. BMC Cancer. 2018; 18(1): 993.

https://doi.org/10.1186/s12885-018-4934-0

PMid:30340559 PMCid:PMC6194639

Epelboym Y, Engelkemier DR, Thomas-Chausse F, Alomari AI, Al-Ibraheemi A, Trenor III CC, et al. Imaging findings in epithelioid hemangioendothelioma. Clin Imaging. 2019; 58: 59-65.

https://doi.org/10.1016/j.clinimag.2019.06.002

PMid:31238187

Kou K, Chen YG, Zhou JP, Sun XD, Sun DW, Li SX, Lv GY. Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy. World J Clin Cases. 2020; 8(18): 3978-3987.

https://doi.org/10.12998/wjcc.v8.i18.3978

PMid:33024754 PMCid:PMC7520791

Jang JK, Thomas R, Braschi-Amirfarzan M, Jagannathan JP. A review of the spectrum of imaging manifestations of epithelioid hemangioendothelioma. Am J Roentgenol. 2020; 215(5): 1290-8.

https://doi.org/10.2214/AJR.20.22876

PMid:32841059

Chu K, Li Z, Tang W, Jiang X. Updated information regarding management of hepatic epithelioid hemangioendothelioma. Intractable Rare Dis Res. 2022; 11(4): 211-4.

https://doi.org/10.5582/irdr.2022.01113

PMid:36457586 PMCid:PMC9709622

Driskill JH, Zheng Y, Wu B-K, Wang L, Cai J, Rakheja D, et al. WWTR1 (TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma. Genes dev. 2021; 35(7-8): 495-511.

https://doi.org/10.1101/gad.348221.120

PMid:33766984 PMCid:PMC8015719

Cournoyer E, Al‐Ibraheemi A, Engel E, Chaudry G, Stapleton S, Adams DM. Clinical characterization and long‐term outcomes in pediatric epithelioid hemangioendothelioma. Pediatr Blood Cancer. 2020; 67(2): e28045.

https://doi.org/10.1002/pbc.28045

PMid:31724797

Sanduzzi-Zamparelli M, Rimola J, Montironi C, Nunes V, Alves VAF, Sapena V, et al. Hepatic epithelioid hemangioendothelioma: an international multicenter study. Dig Liver Dis. 2020; 52(9): 1041-6.

https://doi.org/10.1016/j.dld.2020.05.003

PMid:32535084

Putra J, Gupta A. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis. Pathology. 2017; 49(4): 356-62.

https://doi.org/10.1016/j.pathol.2017.03.001

PMid:28438388

Abdulrahman AA, Yan J, Hou JS. Kaposiform hemangioendothelioma in an adult spleen: An unusual presentation. Hum Pathol: Case Rep. 2017; 10: 15-7.

https://doi.org/10.1016/j.ehpc.2017.04.002

Cao L, Hong J, Zhou L, Ye Y, Liu Y, Yu J, Zheng S. Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience. World J Surg Onc. 2019; 17(1): 1-7.

https://doi.org/10.1186/s12957-019-1729-y

PMid:31699108 PMCid:PMC6839190

Downloads

Published

2026-08-16

How to Cite

Anbardar, M. H., Rahmani, M. A., Ameli, A., Afshinpoor, S., Zaferani Arani, H., & Fooladivanda, N. (2026). Clinico-pathologic Evaluation of Patients with Hemangioendothelioma: A 10-year Experience from Shiraz, Southern of Iran. Galen Medical Journal, 15, e3875. Retrieved from https://journals.salviapub.com/index.php/gmj/article/view/3875

Issue

Section

Original Article